US Patent Issued to Board of Regents, The University of Texas System on June 10 for "Human PD-L1 antibodies and methods of use therefor" (Texas, New Hampshire Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,747, issued on June 10, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"Human PD-L1 antibodies and methods of use therefor" was invented by Michael A. Curran (Houston), Carlo Toniatti (Houston), Ashvin R. Jaiswal (Houston), Dongxing Zha (Houston), Kui Voo (Houston), Bianka Prinz (Lebanon, N.H.) and Nadthakarn Boland (Lebanon, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to antibodies binding to PD-L1 and methods of using such antibodies to treat cancers, such as those that express or overexpress PD-L1."

The patent was filed on Nov. 17, 2022, under Application No. 18/056,71...